SaudePro

EntrarCadastrar-se
  • Google Bookmarks
  • Twitter
  • Windows Live
  • Facebook
  • MySpace
  • Yahoo! Bookmarks
Início » Profissional » Conteúdo Profissional » Dislipdemias » Antioxidantes Nutricionais - Referências Bibliográficas
A+ R A-

Antioxidantes Nutricionais - Referências Bibliográficas

email
  1. Frei, B. Molecular and biological mechanisms of antioxidants action. FASEB, 1999;13: 963-964.
  2. Bjelakovic, G; Nikolova,D; Simonetti,RG; Gluud,C; Lancet; 2004; 364:1219-1228.
  3. Gey,KF. Prospects for tge prevention of free radical disease, regarding câncer and cardiovascular disease. Br Med Bull. 1993;49:679-99.
  4. Stampfer,MJ, Hennekens,CH, Manson, JE, et al. Vitamim E consumption and the risck of coronary disease in women. N Engl J Med. 1993;328:1444-9.
  5. Riemersma, RA, Wood, DA, MacIntyre, CCH, et al. Risk of angina pectoris and plasma concentrations of vitamina A, C, E and carotenoids. Lancet, 1991; 337:1-5.
  6. Ames , BN, Shinenaga, MK, Hagen , TM. Oxidants, antioxidants and the degenerative diseases of aging. Proc N Aca Sci. 1993; 90:7915-22.
  7. Coelho, OR; Cirillo, W. Antioxidantes na prevenção cardiovascular – o fim do mito? Rev Soc Cardiol Estado de São Paulo. 2002; 4:633-9.
  8. Correia, MITD. Antioxidação – o papel das vitaminas. Rev Bras Nutr Clin 2001; 16:59-67.
  9. Galizia, MS, Waitzberg, DL Mecanismo de ação dos radicais livres e antioxidantes Rev Bras Nutr Clin 2001; 16:79-89.
  10. Freedman, BA, Crapo, JD. Biology of disease: free radicals and tissue injury. Lab Invest 1982;47 (5): 412-26.
  11. Souza, HP, Laurindo, FRM Estresse oxidantivo e ruptura da placa aterosclerótica. Rev Soc Cardiol Estado de São Paulo. 2002; 4:584-94.
  12. Leninger , AL , Nelson DL, Cox, MM. Princípios de Bioquímica. 2ed. Sarvier: São Paulo, 1995.
  13. Poehlman,ET, Scheffers,J, Gottieb, SS, Fisher ML, Vaitekevicius P. Incresead resting metabolic rate in patients with heart failure. Ann Intern Med 1995; 121:860-2.
  14. Halliwell B Drug antioxidant effects. Drugs 1991;42:569-605.
  15. Halliwell B Cellular stress and protection mechanism. Biochem Soc Trans 1996; 24:1023-7.
  16. Murray RK. Red and white blood cells. In: Murray RK, Granner DK, mayes PA, Rodwell VW, eds. Harpe´s Biochemistry, 23 ed. Norwalk: Appleton and Lange; 1993 p688-703.
  17. Gutteridge JMC, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trend Biochem Sci 1990; 15:129-35.
  18. Bobbio PA, Bobbio F. Química do Processamento dos Alimentos. 2ed. Varela: São Paulo; 1992.
  19. Fraticelli A, Serrano CV, Bochner BS, et al. Hydrogen peroxide and superoxide modulate leukocyte adhesion molecule expression and leucocyte endothelial adhesion. Biochim Biophys Acta 1996; 1310-251.
  20. Welbourn CRB, Young Y. Endotoxin, septic shock and acute lung injury: neurophils, macrophages and inflammatory mediators. British Journal of Surgery 1992; 79:998-1003.
  21. Parke AL, Ioannides C, Lewis DFV, Parke DV. Molecular pathology of drugs – disease interaction in chronic autoimmune inflammatory disease. Inflammopharmacology 1991; 1:3-36.
  22. Thomas, JA. Estresse oxidativo e defesa contra oxidants. In: Tratado de Nutrição Moderna na Saúde e na Doença. 9 ed. Manole: São Paulo. 2003; p801-812.
  23. Ross AC. Vitamina A e retinóides. In: Tratado de Nutrição Moderna na Saúde e na Doença. 9 ed. Manole: São Paulo. 2003; p325-350.
  24. WHO. Safe vitamin A dosage during pregnacy and lactation. Geneva : WHO;1998 34p (micronutrient series, WHO/NUT/98.4)
  25. Wald C. Carotenoids and visual cycle. J Genet Physiol 1935; 19:351-71.
  26. Dolinsky M, Ramalho A. Deficiência de vitamina A: uma revisão atualizada. Compacta Nutrição. 2003; 4(2):2-18.
  27. Institute of Medicine . Washington . National Academy Press, 2001.
  28. Darlow BA, Graham PJ. Vitamin A supplementation for preventing morbity and mortality in very low birthweight infants. Cochrane Database System Revist 2000;2:501-506.
  29. Stahl W, Sies H. Lycopene:a biologically important carotenoid for humans? Arch Biochem Biophys 1996;336(1): 1-9.
  30. Burton GW Antioxidant action of carotenoids. J Nutrition 1989; 119: 109-11.
  31. Heinonen OP, Huttenen JK, Albanes D, et al. N Engl J Med 1994; 330:1029-35.
  32. Ominen GS, Goodman GE, Thornquist MD, et al N Engl J Med 1996; 334:1150-5.
  33. Erhardt JG, Meisner C, Bode JC, Bode C Lycopene, ß-carotene, and colorectal adenomas Am. J. Clin Nutr 2003; 78: 1219 - 1224.
  34. Slattery ML, Benson J, Curtin K, Ma KN, Schaeffer D, Potter JD Carotenoids and colon cancer 1 Am J Clin Nutr 2000 71: 575-582.
  35. Michaud DS, Feskanich D, Rimm EB, Colditz GA, Speizer FE, Willett WC, Giovannucci E Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts Am J Cli Nut 2000; 72(4):990-997.
  36. Terry P, Jain M, Miller AB, Howe GR, Rohan TE Dietary carotenoids and risk of breast cancer Am. J. Clin Nutr 2002; 76: 883 - 888
  37. Nkondjock A, Ghadirian P Intake of specific carotenoids and essential fatty acids and breast cancer risk in Montreal , Canada . Am. J. Clinical Nutrition 2004; 79: 857 - 864.
  38. Wu K, Erdman JW, Schwartz SJ, Platz EA, Leitzmann M,. Clinton SK , et al Plasma and Dietary Carotenoids, and the Risk of Prostate Cancer Cancer Epidemiol Biom Prev, 2004; 13: 260-269.
  39. Etminan M, Takkouche B, Isorna-Caamano F The role of tomate products and lycopene in the prevention of prostate cancer: a meta analysis of observational studies. Cancer Epodemiol Biomarkers Prev 2004; 13 (3): 340-45.
  40. Mayne ST FASEB J 1996; 10:690-701.
  41. Jacob RA Vitamina C. In: Tratado de Nutrição Moderna na Saúde e na Doença. 9 ed. Manole: São Paulo. 2003; p499-518.
  42. USDA Nutrient Database for Standard Reference, Release 14, 2001.
  43. Stadman ER. Prooxidant activity of ascorbic acid. Am J Clin Nutr 1991; 54:1125S-7S.
  44. Jailal I, Grundy SM, Preservation of the endogenous antioxidant in low density lipoprotein by ascorbate but not probucol during oxidative modification J Clin Invest 1991;87: 597-601.
  45. Thompson KH, Goldin DV. Micronutrients and antioxidants in the progression of diabetes. Nutrition Research 1995;15:1377-410.
  46. Hillstrom RJ, Yacapin-Ammons AK, Lynch SM. Vitamin C inhibits lipid oxidation in human HDL J Nutr 2003; 133:3047-51.
  47. Francis GA High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences. Biochim Biophys Acta 2000; 1483:217-35.
  48. Jacob RA. Introduction: three eras of vitamin C discovery. In: Harris JR ed. Subcellular biochemistry, vol 25. Ascorbic Acid: biochemistry and biomedical cell biology. New York : Plenum Press, 1996: 1-16.
  49. Johnson RA, Baker SS, Fallon JT, Maynard EP, Ruskin JN, Wen Z, et al. An accidental case of cardiomyopathy and selenium deficiency. N Engl J Med 1981; 304:1210-2.
  50. Shenkin A. Micronutrients. In: Rombeau LJ & Rollandeli RH, eds. Enteral and tube feeding. Philadelphia : WB Sauders;1997.p96-111.
  51. Matsumoto S, Matsuo M, Niki E. Oxidation of vitamin E model compound 2,2,5,7,8-pentamethylchroman –6-ol, with the tert-butylperoxyl radical. J Chem Soc Chem Commun 1996:1076-77.
  52. Traber MG. Vitamina E Tratado de Nutrição Moderna na Saúde e na Doença. 9 ed. Manole: São Paulo. 2003; p369-386.
  53. Human Health and Disease, T.K. Basu, J.W. Dickerson, CAB International, 1996.
  54. Kathleen L, Escott-Stump S. Alimentos Nutrição e Dietoterapia. Ed Roca, 1998
  55. GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravivenza nellÍnfarto Miocardico). Dietary supplementation with n-3 polynunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354:447-55.
  56. The Heart Outcomes Prevention Evaluation Study Inverstigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000; 342:154-60.
  57. The Heart Protection Collaborative Group. MRC/BHF Heart Protection Study of antioxidants vitamin supplementation in 20536 high risk individuals: a randomized placebo-controlled trial. Lancet 2002; 360:23-33.
  58. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JCM, et al Dietary Intake of Antioxidants and Risk of Alzheimer Disease JAMA  2002;287:3223-3229.
  59. Lembro A, Sardella A Química. 12 ed. Ática: São Paulo, 1992.
  60. Rice-Evans C, Miller NJ, Paganga G. Struture-antioxidant activity relationships of flavonoids and phenolic acids. Free Radc Biol Med 1996;20:933-956.
  61. Hammerstone JF, Lazarus SA, Schmitz HH. Procyanidin content and variation in some commonly consumed foods. J Nutr 2000; 130: 2086S-92S.
  62. Lazarus, SA, Hammerstone JF, Schmitz HH. Chocolate contains additional flavonoids not found in tea. Lancet 1999; 354:1825.
  63. Arts ICW, van de Putte B, Hollman PCH. Catechin contents of foods commonly consumed in The Netherlands J Agric Food Chem. Tea, wine, fruit juices, and chocolate milk. 2000;48:1752-57.
  64. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary antioxidants flavonoids and risk for coronary heart disease: the Zutphen Elderly Study. Lancet 1993; 342:1007-11.
  65. Yang CS, Chung JY, Yang G, et al. Tea and tea polyphenols in cancer prevention J Nutr 2000;130:4725-85.
  66. De Logeril M et al. Circulation.1999; 99: 779-85
  67. Visioli F, Galli C Componentes antiaterogênicos do azeite de oliva. Current Atheros Rep Brasil. 2001; 1:107-13.
  68. Visioli F, Borsani L, Galli C. Diet and prevention of coronary heart disease: the potential role of phytochemicals. Cardiovasc Res 2000: 47:55-60.
  69. Marsilio V, Campestre C, Lanza B. Phenolic compounds change during California-style ripe olive processind. Food Chem. 2001;74:55-60.
  70. Carluccio MA, Siculella L, Ancora MA, massaro M, Scoditti E, et al. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation Arterioscler Thromb Vasc Biol. 2003; 23:622-29.
  71. Bertelli AA, Gozzini A, Stradi R, Stella S, Bertelli A. Stability of resveratrol over time and in the various stages of grape transformation. Drugs Exp Clin Res 1998;24:207-211.
  72. Andlauer W et al. Clin Nutr Metab Care, 1:539-47,1998
  73. Costa RP, Silva CC, Pimentel IC Hábito alimentar e dislipidemias- Fundamentos para orientação dietética. In: Manual de dislipidemias e cardiometabolismo. São Paulo: BBS editora, 2004.
  74. Da Luz PL et al. Experimental and Molecular Pathology1999; 65:150-159
  75. III Diretrizes Brasileiras sobre Dislipidemia e Diretriz de Prevenção da Aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol 77 (Supl III), nov 2001.
  76. PEREIRA, MA; JACOBS, DR Jr; PINS, JJ; et al. Effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults. Am J Clin Nutr; 75:848:55, 2002.
  77. SLAVIN, J; JACOBS, D; MARQUART, L. Whole grain consuption and chronic disease: protective mechanisms. Nutr Cancer1997; 27:14-21.
  78. SLAVIN, JL; MARTINI, MC; JACOBS, DR Jr; MARQUART, L. Plausible mechanisms for the protectiveness of whole grains. Am J Clin Nutr 1999; 70(suppl):459S-63S,.
  79. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, et al. The SU.VI.MAX study: a randomized, placebo-controlled trial of the health effects of antioxidants vitamins and minerals. Arch Intern Med, 2004 (in press)
Saiba mais sobre outros conteúdos relacionados
Receba os nossos news letters com as novidades e recentes diretrizes
Participe de enquetes e concorra a diversos premios e promoções
Faça o seu cadastro e entre no universo da nutrição
Seja um parceiro do IMeN
Quero me cadastrar agora:

IMeN - Instituto de Metabolismo e Nutrição • © 2009 nutricaoclinica.com.br
Rua Carlos Sampaio, 304 conj 21-31 • São Paulo • SP
Fone: (11) 3287-1800 • 3253-2966
imen@nutricaoclinica.com.br

Entrar